Amedisys Sees Hospice Admissions Dip Despite Revenue Growth
Hospice News
NOVEMBER 7, 2024
Rate increases and home health volume growth were offset by raises, wage inflation, a shift in home health mix, investments in hospice clinical staffing and higher compensation and benefit costs,” Amedisys indicated in slides accompanying its earnings release. Amedisys’ year-to-date adjusted EBITDA reached $191.1
Let's personalize your content